397 related articles for article (PubMed ID: 14600276)
41. Protection by pyridostigmine bromide of marmoset hemi-diaphragm acetylcholinesterase activity after soman exposure.
Haigh JR; Adler M; Apland JP; Deshpande SS; Barham CB; Desmond P; Koplovitz I; Lenz DE; Gordon RK
Chem Biol Interact; 2010 Sep; 187(1-3):416-20. PubMed ID: 20144889
[TBL] [Abstract][Full Text] [Related]
42. Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?
Maxwell DM; Brecht KM; Koplovitz I; Sweeney RE
Arch Toxicol; 2006 Nov; 80(11):756-60. PubMed ID: 16770629
[TBL] [Abstract][Full Text] [Related]
43. An assessment of comparative acute toxicity of diisopropyl-fluorophosphate, tabun, sarin, and soman in relation to cholinergic and GABAergic enzyme activities in rats.
Sivam SP; Hoskins B; Ho IK
Fundam Appl Toxicol; 1984 Aug; 4(4):531-8. PubMed ID: 6479498
[TBL] [Abstract][Full Text] [Related]
44. Prophylaxis with human serum butyrylcholinesterase protects guinea pigs exposed to multiple lethal doses of soman or VX.
Saxena A; Sun W; Fedorko JM; Koplovitz I; Doctor BP
Biochem Pharmacol; 2011 Jan; 81(1):164-9. PubMed ID: 20846507
[TBL] [Abstract][Full Text] [Related]
45. Repeated low-dose exposures to sarin, soman, or VX affect acoustic startle in guinea pigs.
Smith CD; Lee RB; Moran AV; Sipos ML
Neurotoxicol Teratol; 2016; 54():36-45. PubMed ID: 26829110
[TBL] [Abstract][Full Text] [Related]
46. Biomarkers of low-level exposure to soman vapor: comparison of fluoride regeneration to acetylcholinesterase inhibition.
Dabisch PA; Davis EA; Renner JA; Jakubowski EM; Mioduszewski RJ; Thomson SA
Inhal Toxicol; 2008 Jan; 20(2):149-56. PubMed ID: 18236229
[TBL] [Abstract][Full Text] [Related]
47. Anticonvulsive and protective effects of diazepam and midazolam in rats poisoned by highly toxic organophosphorus compounds.
Bokonjić D; Rosić N
Arh Hig Rada Toksikol; 1991 Dec; 42(4):359-65. PubMed ID: 1815490
[TBL] [Abstract][Full Text] [Related]
48. The effects of repeated low-dose sarin exposure.
Shih TM; Hulet SW; McDonough JH
Toxicol Appl Pharmacol; 2006 Sep; 215(2):119-34. PubMed ID: 16556454
[TBL] [Abstract][Full Text] [Related]
49. The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin.
Davies HG; Richter RJ; Keifer M; Broomfield CA; Sowalla J; Furlong CE
Nat Genet; 1996 Nov; 14(3):334-6. PubMed ID: 8896566
[TBL] [Abstract][Full Text] [Related]
50. Interaction of pentylsarin analogues with human acetylcholinesterase: a kinetic study.
Worek F; Herkert NM; Koller M; Aurbek N; Thiermann H
Toxicol Lett; 2009 Jun; 187(2):119-23. PubMed ID: 19429253
[TBL] [Abstract][Full Text] [Related]
51. Detoxification of nerve agents by a substituted beta-cyclodextrin: application of a modified biological assay.
Wille T; Tenberken O; Reiter G; Müller S; Le Provost R; Lafont O; Estour F; Thiermann H; Worek F
Toxicology; 2009 Nov; 265(3):96-100. PubMed ID: 19800384
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the therapeutic efficacy of some antimuscarinics against soman in vivo.
Lau WM; Lewis KJ; Dawson RM
J Appl Toxicol; 1996; 16(5):423-30. PubMed ID: 8889794
[TBL] [Abstract][Full Text] [Related]
53. Acute toxicity of organophosphorus compounds in guinea pigs is sex- and age-dependent and cannot be solely accounted for by acetylcholinesterase inhibition.
Fawcett WP; Aracava Y; Adler M; Pereira EF; Albuquerque EX
J Pharmacol Exp Ther; 2009 Feb; 328(2):516-24. PubMed ID: 18984651
[TBL] [Abstract][Full Text] [Related]
54. Acute sarin exposure causes differential regulation of choline acetyltransferase, acetylcholinesterase, and acetylcholine receptors in the central nervous system of the rat.
Khan WA; Dechkovskaia AM; Herrick EA; Jones KH; Abou-Donia MB
Toxicol Sci; 2000 Sep; 57(1):112-20. PubMed ID: 10966517
[TBL] [Abstract][Full Text] [Related]
55. In vitro reactivation potency of some acetylcholinesterase reactivators against sarin- and cyclosarin-induced inhibitions.
Kuca K; Cabal J; Jun D; Kassa J; Bartosová L; Kunesová G
J Appl Toxicol; 2005; 25(4):296-300. PubMed ID: 16025528
[TBL] [Abstract][Full Text] [Related]
56. Interaction of exposure concentration and duration in determining acute toxic effects of sarin vapor in rats.
Mioduszewski R; Manthei J; Way R; Burnett D; Gaviola B; Muse W; Thomson S; Sommerville D; Crosier R
Toxicol Sci; 2002 Apr; 66(2):176-84. PubMed ID: 11896284
[TBL] [Abstract][Full Text] [Related]
57. Changes of cholinesterase activity in the erythrocytes, plasma, diaphragm, liver and various parts of the brain in the rabbit following transfusion of erythrocytes with soman inhibited acetylcholinesterase.
Kassa J; Bajgar J; Fusek J
Acta Medica (Hradec Kralove); 1997; 40(2):37-9. PubMed ID: 9389209
[TBL] [Abstract][Full Text] [Related]
58. In vitro detoxification of cyclosarin in human blood pre-incubated ex vivo with recombinant serum paraoxonases.
Ashani Y; Goldsmith M; Leader H; Silman I; Sussman JL; Tawfik DS
Toxicol Lett; 2011 Sep; 206(1):24-8. PubMed ID: 21807078
[TBL] [Abstract][Full Text] [Related]
59. Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride.
Petroianu GA; Schmitt A; Arafat K; Hasan MY
Int J Toxicol; 2005; 24(2):79-86. PubMed ID: 16036766
[TBL] [Abstract][Full Text] [Related]
60. The specificity of carboxylesterase protection against the toxicity of organophosphorus compounds.
Maxwell DM
Toxicol Appl Pharmacol; 1992 Jun; 114(2):306-12. PubMed ID: 1609424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
